← Open Payments lookup

DAVID MILLER: Open Payments

NPI 1538140413 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$838 in 39 payments from 19 companies in 2025. Trend: 2023 $653 · 2024 $790 · 2025 $838

Food & beverage: $818Education: $20
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.6$139
Merck Sharp & Dohme LLC5$117
Bayer Healthcare Pharmaceuticals Inc.4$76
Amgen Inc.4$66
Novartis Pharmaceuticals Corporation3$62
PFIZER INC.3$57
Alnylam Pharmaceuticals Inc.1$37
AstraZeneca Pharmaceuticals LP2$36
ABIOMED1$36
Daiichi Sankyo Inc.1$29

Products named: ELIQUIS, Kerendia, VERQUVO, Repatha, LEQVIO, CAPVAXIVE, VYNDAQEL, AMVUTTRA.

Industry payments across CA — which companies pay providers there.